Search Within

MSK Grad Students

Formats
  1. Journal Article (1662)
  2. Meeting Abstract (985)
  3. Review (108)
  4. Editorial (42)
  5. Research Letter (36)
  6. Miscellaneous (20)
  7. Correspondence (15)
  8. Conference Paper (12)
  9. Book Section (9)
  10. Guidelines (6)
Groups
  1. GSK Faculty (2027)
  2. Department of Medicine (1628)
  3. Sloan Kettering Institute Postdocs (1609)
  4. Sloan Kettering Institute Faculty (1316)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1186)
  6. Center for Hematologic Malignancies (1136)

More Groups

People
  1. Sergio Giralt (400)
  2. Miguel-Angel Perales (385)
  3. Parastoo Dahi (305)
  4. Sean Devlin (285)
  5. Doris Ponce (257)
  6. Roni Tamari (213)

More People

Years
  1. 2025 (132)
  2. 2024 (273)
  3. 2023 (312)
  4. 2022 (334)
  5. 2021 (289)
  6. 2020 (378)

More Years

Publications
  1. Blood (311)
  2. Biology of Blood and Marrow Transplantation (165)
  3. Cancer Research (132)
  4. Journal of Clinical Oncology (130)
  5. Nature Communications (96)
  6. Nature (87)

More Publications

Publishers
  1. Nature Publishing Group (440)
  2. American Society of Hematology (350)
  3. Elsevier Inc. (298)
  4. Cell Press (278)
  5. American Association for Cancer Research (267)
  6. American Society of Clinical Oncology (147)

More Publishers

Results (2895)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The lipid droplet protein DHRS3 is a regulator of melanoma cell state
    Journal Article

    Johns, E.; Ma, Y.; Louphrasitthiphol, P.; Peralta, C.; Hunter, M. V.; Raymond, J. H.; Molina, H.; Goding, C. R.; White, R. M.
    Pigment Cell & Melanoma Research (2025)

    Fulltext@MSK | Save
  • Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancer
    Journal Article

    Mack, K. N.; Bauer, D.; Carter, L. M.; Carrasco, S. E.; Atmane, M. I.; Viray, T. D.; Brooks, C. L.; Hollingsworth, M. A.; Radhakrishnan, P.; Lewis, J. S.
    Nuclear Medicine and Biology (2025)

    Fulltext@MSK | Save
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Uncovering the HOXA9 translational regulatory complex that promotes AML leukemic stem cells
    Meeting Abstract

    Xie, X.; Chavez, F. H.; Baali, I.; Chu, E. L.; Evans, C.; Yang, X.; Wei, W.; Luo, H.; Park, S. M.; Chang, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschè‚nes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Disparities in microbiota diversity impacting non-European recipients of 8/8 HLA-matched unrelated donor transplantation
    Meeting Abstract

    Smith, N. G.; Fingrut, W. B.; Waters, N.; Piasevoli, K.; Fei, T.; Slingerland, J.; Peled, J. U.; Ponce, D. M.
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab versus lenalidomide as maintenance therapy in newly diagnosed multiple myeloma- Interim efficacy results of a randomized clinical trial
    Meeting Abstract

    Rajeeve, S.; Derkach, A.; Devlin, S. M.; Santos, J.; Przemielewska, A.; Sood, T.; Maclachlan, K. H.; Hashmi, H.; Tan, C. R.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A Proof-of-principle of split-course bridging radiotherapy (SC-BRT) prior to CAR T-cell therapies for relapsed or refractory B-cell lymphomas: A phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K. K.; Boardman, A. P.; Dahi, P. B.; Shah, G. L.; Scordo, M.; Park, J. H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Very low dose radiotherapy (VLDRT) with 4 Gy for potentially-curable indolent non-Hodgkin lymphomas
    Meeting Abstract

    Mankuzhy, N. P.; Imber, B. S.; Pammer, P.; Fregonese, B.; Cajo, A.; Cederquist, G.; Dreyfuss, A.; Lapen, K.; Patel, R. R.; Moore, Z. R.; more...
    Blood (2024)

    Fulltext@MSK | Save